HAYA Therapeutics headquarters details
- City
- Lausanne
- State / region
- Canton de Vaud
- Country
- Switzerland
- Founded
- 2017
- Website
- hayatx.com
Location map
Open in Google MapsAll HAYA Therapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Lausanne HQ | Canton de Vaud | Switzerland | Headquarters |
Showing the headquarters of 3 recorded locations. See every location in GraphIQ →
About HAYA Therapeutics
HAYA Therapeutics is headquartered in Lausanne, Canton de Vaud, Switzerland. Founded in 2017, the company has 3 recorded locations across 2+ countries and employs approximately 41 people worldwide.
Where is HAYA Therapeutics's main office?
HAYA Therapeutics's main headquarters office is located at Lausanne, Canton de Vaud, Switzerland. This is the company's primary corporate address.
HAYA Therapeutics regional offices
Beyond its headquarters in Lausanne, HAYA Therapeutics has recorded locations in Switzerland and United States.
What does HAYA Therapeutics do?
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome. The company leverages its proprietary platform to uncover new insights into disease-associated cell states and the long non-coding RNAs (lncRNAs) that control them. Its lead candidate, HTX-001, is being developed as a potential treatment for heart failure. In addition, the company is advancing a pipeline of precision therapies that target lncRNAs for cell-specific treatment of conditions affecting other tissues.
Frequently asked questions
Where is HAYA Therapeutics headquarters?
HAYA Therapeutics's headquarters is located at Lausanne, Canton de Vaud, Switzerland.
How many offices does HAYA Therapeutics have?
GraphIQ records 3 locations for HAYA Therapeutics across 2+ countries, as of October 2026.
When was HAYA Therapeutics founded?
HAYA Therapeutics was founded in 2017 and employs approximately 41 people.
How many employees does HAYA Therapeutics have?
HAYA Therapeutics has approximately 41 employees (GraphIQ estimate, 2026).